Figure 1
Cumulative incidence of CVE on nilotinib according to the level of HC.

Cumulative incidence of CVE on nilotinib according to the level of HC.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal